Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID‐19) infection: Perspectives from Taiwan
Open Access
- 7 April 2020
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 128 (5), 309-316
- https://doi.org/10.1002/cncy.22280
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyThe New England Journal of Medicine, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agentsInfection Prevention in Practice, 2020
- The outbreak of COVID-19: An overviewJournal of the Chinese Medical Association, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family clusterThe Lancet, 2020
- China coronavirus: Six questions scientists are askingNature, 2020
- Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contaminationJournal of Hospital Infection, 2015
- Laboratory Safety Aspects of SARS at Biosafety Level 2Annals of the Academy of Medicine, Singapore, 2004
- Detection of SARS Coronavirus in Patients with Suspected SARSEmerging Infectious Diseases, 2004